|Articles|April 1, 2000

Underuse of Beta-Blockers in Heart Failure: How to Improve Outcomes
Volume 6
Issue 6 Suppl

Cardiodynamic Effects and Mechanisms of Action of Beta-Blockers

Author(s)Barry H. Greenberg, MD

Download PDF: Cardiodynamic Effects and Mechanisms of Action of Beta-Blockers

Articles in this issue

over 26 years ago

Article

Participating Faculty

over 26 years ago

Article

Introduction

over 26 years ago

Article

Underuse of Beta-Blockers in Cardiovascular Medicine

over 26 years ago

Article

The Effect of Beta-Blockers on Morbidity and Mortality Associated with Heart Failure

over 26 years ago

Article

Dispelling the Myth: Incorporating Beta-Blockers into Practice Guidelines

over 26 years ago

Article

Bibliography

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Woman getting her eyes checked | Image credit: N F/peopleimages.com - stock.adobe.com

Understanding Barriers to Diabetic Eye Care for Alabama’s Underserved Patients

ByStella Ko, PharmD, MS,David Tabano, PhD,Mona Kilany, PhD,Kimberly Jinnett, PhD, MSPH,Victor Kirksey, PhD,Reg Ledesma, MS,Sarah Mossburg, PhD,Charlene Nguyen, MPP, BSc,Bryan A. Wilson, PhD, MBA

September 15th 2026

Doctor talking with patient | Image credit: Prostock-studio - stock.adobe.com

Teach-Back Is Essential Care Infrastructure: A Low-Cost Strategy for Safer, More Equitable Care

ByAayush Sisodia, MSHI, BDS

September 15th 2026

Man with chest pain | Image credit: Liubomir - stock.adobe.com

The Right Care Initiative: Promoting Accountable Care to Prevent Cardiovascular Death

ByHector P. Rodriguez, PhD, MPH, Hattie R. Hanley, MPP,Stephen M. Shortell, PhD, MBA, MPH

September 15th 2026

Pregnant woman | Image credit: pressmaster - stock.adobe.com

Early Signs of Success for Missouri’s New Notification of Pregnancy

ByAbigail R. Barker, PhD,Nadim Kanafani, MD,Kelley M. Peters, MS, RN, BSN,Rashmi Srivastava, MD, BS

September 15th 2026

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Cardiodynamic Effects and Mechanisms of Action of Beta-Blockers

Articles in this issue

Related Content

Understanding Barriers to Diabetic Eye Care for Alabama’s Underserved Patients

Teach-Back Is Essential Care Infrastructure: A Low-Cost Strategy for Safer, More Equitable Care

The Right Care Initiative: Promoting Accountable Care to Prevent Cardiovascular Death

Early Signs of Success for Missouri’s New Notification of Pregnancy

Predicting GLP-1 Discontinuation From Pharmacy Claims

Trending on AJMC

FDA Clears First Alzheimer Blood Test for Adults as Young as 40

RSV Vaccine Shows 100% Effectiveness in COPD: Jorgen Vestbo, MD

5 Things to Know About the 2026 ESC Heart Failure Guidelines

FDA Shortens Tarlatamab Monitoring, Widens Access to SCLC Care

Enlicitide, Oral PCSK9 Inhibitor, Cuts LDL 60% in CORALreef Trials